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Introduction
Proper spindle assembly is critical for chromosome alignment 
and segregation during meiotic and mitotic cell divisions. The 
first meiosis in female mammals is extraordinary, because it 
arises from a state of prophase arrest that, depending upon the 
species, can persist for many decades from birth. Defects in 
spindle formation during this division correlate with chromo-
some segregation errors and are a leading cause of infertility 
and embryonic aneuploidy (Hassold and Hunt, 2001). In so-
matic animal cells and spermatocytes, the pericentriolar mate-
rial (PCM) component of centrosomes nucleates microtubules 
that “search and capture” chromosomes as the bipolar spindle 
forms (Kirschner and Mitchison, 1986a,b). However, spindle 
assembly can still occur after elimination of functional centro-
somes in cultured cells (Khodjakov et al., 2000; Mahoney et 
al., 2006) or the whole organism (Megraw et al., 2001; Azimza-
deh et al., 2012). Centrosomes do, however, enhance mitotic 
fidelity (Delattre and Gönczy, 2004; Zamora and Marshall, 
2005; McCoy et al., 2015). Nevertheless, in most metazoans, 
centrioles are naturally eliminated during oogenesis before fe-
male meiosis (Delattre and Gönczy, 2004) Thus, high fidelity of 
chromosome transmission during meiosis I in the oocyte, essen-
tial to correctly establish the next generation, relies on acentro-
somal spindle assembly (Heald et al., 1996).
The small GTPase Ran was the first molecule found to 
regulate acentrosomal microtubule nucleation. Its role has been 
most extensively studied in Xenopus laevis extracts (Kalab et 
al., 1999; Ohba et al., 1999; Wilde and Zheng, 1999), where 
a gradient of GTP-bound Ran around chromatin promotes the 
release of spindle assembly factors from inhibitory importins 
(Caudron et al., 2005; Bastiaens et al., 2006; Kaláb et al., 2006; 
Forbes et al., 2015). Although the Ran-GTP pathway increases 
microtubule density around chromosomes in mouse oocytes 
(Schuh and Ellenberg, 2007), neither interfering with Ran-GTP 
itself in mouse (Dumont et al., 2007; Schuh and Ellenberg, 
2007) or Xenopus (Dumont et al., 2007) oocytes nor inhibit-
ing certain Ran effectors such as hepatoma up-regulated protein 
(Breuer et al., 2010), it prevents meiosis I spindle assembly. 
These observations, strengthened by the finding that enucleated 
oocytes do not develop any spindle-like structure (Schuh and 
Ellenberg, 2007), led to the suggestion that alternative factors 
must promote spindle formation during the resumption of mei-
osis I after prolonged arrest. Importantly, such limiting fac-
tors governing the kinetics of the early stages of microtubule 
assembly to form a functional meiosis I spindle remain to be 
identified. This raises a fundamental question: how is spindle 
formation initiated during the first meiotic division?
Establishing the bipolar spindle in mammalian oocytes after their prolonged arrest is crucial for meiotic fidelity and 
subsequent development. In contrast to somatic cells, the first meiotic spindle assembles in the absence of centriole- 
containing centrosomes. Ran-GTP can promote microtubule nucleation near chromatin, but additional unidentified fac-
tors are postulated for the activity of multiple acentriolar microtubule organizing centers in the oocyte. We now demon-
strate that partially overlapping, nonredundant functions of Aurora A and Plk4 kinases contribute to initiate acentriolar 
meiosis I spindle formation. Loss of microtubule nucleation after simultaneous chemical inhibition of both kinases can be 
significantly rescued by drug-resistant Aurora A alone. Drug-resistant Plk4 can enhance Aurora A–mediated rescue, 
and, accordingly, Plk4 can phosphorylate and potentiate the activity of Aurora A in vitro. Both kinases function distinctly 
from Ran, which amplifies microtubule growth. We conclude that Aurora A and Plk4 are rate-limiting factors contribut-
ing to microtubule growth as the acentriolar oocyte resumes meiosis.
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A partial explanation is provided by the presence of mul-
tiple microtubule organizing centers (MTOCs) in the oocyte 
cytoplasm (Maro et al., 1985; Messinger and Albertini, 1991; 
Van Blerkom, 1991; Combelles and Albertini, 2001). Although 
acentriolar, these MTOCs contain PCM components, including 
CEP192 (Clift and Schuh, 2015), γ-tubulin (Gueth-Hallonet et 
al., 1993; Palacios et al., 1993), and pericentrin (Carabatsos et 
al., 2000). Studies of meiotic maturation in live oocytes (Schuh 
and Ellenberg, 2007) have revealed that the MTOCs closely sur-
round the nucleus and contribute to an increase in microtubule 
density at the time of nuclear envelope breakdown (NEBD). 
However, the regulatory components that enable the initiation 
of microtubule nucleation and growth after the oocyte’s pro-
longed arrest in prophase are still unknown.
Here, we have discovered that Plk4 and Aurora A to-
gether contribute to trigger rapid growth of microtubules at 
initial stages of spindle formation in the acentriolar mouse oo-
cyte. Combining chemical genetics with live imaging analysis, 
we demonstrate an overlapping function of these two kinases 
in initiating microtubule growth in formation of the meiosis 
I spindle. Inhibition of either Plk4 or Aurora A kinase alone 
leads to a diminution of microtubule growth after NEBD in a 
manner characteristic for each kinase. However, extreme loss 
of microtubule nucleation results from simultaneous inhibition 
of both kinases. We present evidence that the two kinases have 
both independent and interdependent roles in microtubule nu-
cleation. These functions are independent of the Ran pathway, 
which acts to amplify microtubule growth to promote formation 
of the acentriolar spindle in the extended prometaphase of this 
critical first meiotic division.
Results
MTOC-associated Plk4 contributes to 
microtubule nucleation upon resumption 
of meiosis
In considering which factors might promote microtubule nucle-
ation in the oocyte upon resumption of meiosis, we first asked 
whether they might be similar to those required for spindle 
formation from acentriolar MTOCs in the early mouse embryo 
(Coelho et al., 2013). It was shown in the embryo that this re-
quires Plk4, a protein kinase more widely known for its roles in 
centriole duplication (Bettencourt-Dias et al., 2005; Habedanck 
et al., 2005). To determine whether Plk4 might also have a sim-
ilar role in the acentriolar mouse oocyte, we first chose to treat 
oocytes with centrinone, a potent and selective small-molecule 
inhibitor of Plk4 (Wong et al., 2015). To visualize the dynam-
ics of growing microtubules and chromosomes, we coinjected 
germinal vesicle–stage oocytes with mRNAs for EGFP-EB3 
and histone H2B-mRFP and measured the increase in size of 
the projected spindle area with time. Zero time (00:00) was es-
tablished as the time when EB3-GFP signal was first observed 
inside the nucleus, indicating NEBD. In control oocytes, we 
observed microtubule growth from MTOCs surrounding the 
condensed chromosomes, as previously described (Schuh and 
Ellenberg, 2007), leading to assembly of a robust spindle after 
NEBD (zero time). After centrinone treatment, bipolar spindles 
still formed but with a strikingly slower kinetics. Because we 
observed a delay in the initial nucleation of microtubules, we 
quantified the projected spindle area over an interval of 2 h after 
NEBD during which control oocytes reach 80% of the plateau 
level. To compare the effects of inhibiting Plk4 function, we 
noted both the extent of microtubule nucleation within this time 
period and the time taken for the spindle to reach 50% of its 
maximal expansion within this 2-h interval (t502h; see Materials 
and methods). We found that the spindles of centrinone-treated 
oocytes developed to 51% of the size of control spindles by 2 h 
and required 55.4 ± 3.8 min to reach 50% of their size at 2 h 
(Fig. 1, A, B, and E; Table S2; and Video 1).
These observations suggested that Plk4 is required for ef-
ficient nucleation of microtubules in the acentriolar oocyte just 
as it is in the early embryo (Coelho et al., 2013). However, in 
contrast to the early embryo, where Plk4 depletion or expres-
sion of dominant-negative Plk4 results in monopolar spindles, 
bipolar spindles still formed in centrinone-treated oocytes. To 
ensure that this was not a peculiarity of the pharmacological 
inhibition of Plk4, we treated embryos with centrinone and 
monitored spindle formation. This resulted in monopolar spin-
dle formation (Fig. S1), recapitulating the phenotype observed 
previously (Coelho et al., 2013). Thus, the reduced kinetics of 
microtubule nucleation we observe in centrinone-treated oo-
cytes is likely to result from Plk4 inhibition.
Notwithstanding this finding, a difficulty in using phar-
macological approaches to inhibit protein kinases is that, to 
our knowledge, without exception, no small-molecule inhibitor 
is completely specific for a single target. Thus, to validate the 
target, we created a drug-resistant allele of murine Plk4 (Plk4 
G95R), which, based on previous studies with human PLK4 
(Scutt et al., 2009; Sloane et al., 2010), spares catalytic activ-
ity and is resistant to various “type I” ATP-competitive protein 
kinase inhibitors. The drug-resistant Plk4 variant was 67.4% ef-
fective at rescuing the effects of centrinone treatment at the very 
early stages of microtubule nucleation after NEBD in mouse 
oocytes (Fig. 1, C and E; and Video 1). That this mutant did 
not fully rescue in vivo could be explained if centrinone pos-
sesses another (unknown) target in oocytes that is required for 
microtubule growth. Moreover, we cannot rule out that G95R 
Plk4 might possess a subtly different catalytic activity or sub-
strate specificity when expressed in cells, although we consider 
this unlikely. Nevertheless, the 67.4% rescue achieved by Plk4 
G95R indicates a substantial involvement of Plk4 in the initia-
tion of microtubule nucleation.
To determine whether the effect of centrinone could be 
attributed to Plk4 inhibition, we used the alternative method of 
microinjecting germinal vesicle–stage oocytes with synthetic 
mRNA encoding Plk4Δkinase. This Plk4 variant was previ-
ously shown to exhibit a dominant-negative effect upon micro-
tubule nucleation at mouse embryo acentriolar MTOCs (Coelho 
et al., 2013). We found that in oocytes expressing Plk4Δkinase, 
the projected spindle area reached only 40.8% of control at 2 h 
and spindles assembled with slower kinetics (t502h = 74 ± 4.2 
min compared with 38.7 ± 7.8 min in controls; Fig. 1, A, D, and 
E; Table S2; and Video 1). This effect is extremely similar to 
that of centrinone treatment.
These observations led us to consider whether Plk4 might 
be associated with the MTOCs, which are known to contain sev-
eral molecules associated with PCM of conventional centrosomes 
(Gueth-Hallonet et al., 1993; Palacios et al., 1993; Carabatsos 
et al., 2000). In accord with this notion and in agreement with 
the finding of Plk4 at the acentriolar MTOCs of early mouse 
embryos (Coelho et al., 2013), we found that Plk4 was enriched 
near condensing chromosomes and on cytoplasmic MTOCs in 
the vicinity of the centrosomal protein Cep192 (Fig. 1, F and G).
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Collectively, these experiments indicate that Plk4 is asso-
ciated with MTOCs where it participates in triggering microtu-
bule nucleation after the prolonged state of premeiotic prophase 
arrest, just as it does in the early embryo. However, in contrast 
to the early embryo, a bipolar spindle did eventually form in 
the oocyte in the absence of Plk4 function (Fig. 2). Thus, other 
factors are able to support sufficient microtubule nucleation 
to enable spindle formation in the absence of Plk4, and this is 
reflected in residual microtubule nucleation that we still see 
when Plk4 is inhibited in the oocyte.
Aurora A also contributes to the initiation 
of microtubule nucleation
In considering whether other protein kinases might promote 
microtubule nucleation in the oocyte, we investigated poten-
tial roles of Aurora A and Plk1, because these centrosome- 
Figure 1. Plk4 localizes to MTOCs in the mouse 
oocyte and facilitates microtubule growth upon 
resumption of meiosis. (A-E) Time-lapse series 
of oocytes injected with mRNA encoding 
EGFP-EB3 (gray, top; inverted, bottom) and 
histone H2B-mRFP (red, top). Oocytes were 
imaged as controls (A), under Plk4 inhibition 
by treatment with 5  µM centrinone (B), after 
coinjection of mRNA encoding the centrinone-
resistant point mutant Plk4G95R the in 
presence of 5  µM centrinone (C), or while 
coexpressing Plk4Δkinase (D). Time (in hours 
:minutes) relative to NEBD. See Video  1.   
(E) Quantification of the size of the projected 
spindle area. Plk4 inhibition by expression of 
the dominant-negative Plk4Δkinase (GFP-ΔK; n 
= 13) or by treatment with centrinone at 5 µM 
(n = 26). Centrinone significantly reduces the 
kinetics of microtubule growth, as determined 
by the size of the spindle area, compared 
with controls (n = 44). Defects caused by 
centrinone treatment are significantly rescued 
by coexpression of Plk4G95R (n = 25). Error 
bars indicate SEM. P-values are shown in Table 
S1. See also Video 1. (F and G) Localization of 
Plk4 at MTOCs, revealed by immunostaining 
of oocytes with anti-Plk4, anti-CEP192, and 
anti–α-tubulin antibodies, in the indicated 
colors. DNA is shown in blue. Bars, 10 µm.
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Figure 2. Aurora A, Plk4, or Plk1 inhibition differently affect meiosis I progression. Time-lapse series of mouse oocytes expressing EGFP-EB3 (green, 
top; gray, bottom) and histone H2B-mRFP (red, top). Depicted are controls (A), oocytes treated with 2 µM centrinone (B), oocytes under Plk1 inhibition by 
treatment with 100 nM of the Plk1 inhibitor BI2536 (C), and oocytes treated with 1 µM Aurora A inhibitor 1 (AurA Inh 1) and 500 nM MLN8237 (E). Time 
in hours :minutes relative to NEBD. (A–E) Representative still images from NEBD until establishment of spindle bipolarity, anaphase I onset, and polar body 
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associated kinases possess this function in the PCM in mito-
sis (Marumoto et al., 2005; Barr and Gergely, 2007; Archam-
bault and Glover, 2009). To this end, we treated mouse oocytes 
with target-validated potent small-molecule inhibitors of Au-
rora A (Aurora A inhibitor 1 [Aliagas-Martin et al., 2009] and 
MLN8237 [Sloane et al., 2010]) or Plk1 (BI2536; Steegmaier et 
al., 2007; Scutt et al., 2009).
We found that treatment of oocytes with either Aurora A 
inhibitor 1 or MLN8237 (Fig.  2, D–F; Fig.  3, A–C; Fig. S2; 
Table S3; and Video 2) significantly reduced the final spindle 
area to 32.7% or 36% of controls, respectively (Fig. 3 G). Treat-
ment with either Aurora A inhibitor 1 or MLN8237 treatment 
also slowed the kinetics of spindle expansion, reflected in an 
increased t502h from 38.7 ± 7.8 min in controls to 55 ± 2.8 or 
72.77 ± 1.4 min after the respective treatments (Table S2). This 
largely reflected a lag in the initiation of microtubule nucleation 
(Fig. 3, B, C, and G). Expression of a drug-resistant Aurora A 
variant restored 76% of microtubule growth in a 2-h period after 
Aurora A inhibitor I treatment (G229L; Fig. S2 D and Video 2). 
When we followed the effects of Aurora A inhibition over an 
extended interval of up to 18 h, we found that the time taken to 
establish a bipolar spindle (Fig. 2, D and E; and Fig. 3 E) and 
the time spent in prometaphase (Fig.  3  F) were both signifi-
cantly increased. Metaphase (judged visually by the alignment 
of chromosomes at the spindle’s equatorial zone; see also Ma-
terials and methods) was eventually attained, and oocytes then 
undertook the first meiotic division (Fig. 2 and Fig. 3, E and F).
In contrast to the effects of Aurora A inhibition, there was 
no lag in the onset of spindle microtubule growth in BI2536-
treated versus control oocytes, and the time taken for micro-
tubules to grow to 50% of their levels at 2  h was much less 
affected (t502h = 41.1 ± 7.3 min; Fig. 3, D and G; and Table S2). 
Microtubule density was diminished 2 h after Plk1 inhibition 
to 56.0% of control levels. However, the effect on microtubule 
density was not as dramatic as after inhibition of either Plk4 
or Aurora A (Figs. 2 F and 3 G). This is in accord with the 
observations of Clift and Schuh (2015), who found that inhibi-
tion of Plk1 did not significantly reduce the amount of microtu-
bules at MTOCs, although it did prevent MTOC fragmentation 
into multiple microtubule organizing bodies. Our observations 
of a delay in establishing spindle bipolarity with an extended 
prometaphase culminating in arrest in a metaphase-like state 
(Fig. 2, C and G; Fig. 3, D–F; and Table S3) are also consistent 
with these previous observations (Clift and Schuh, 2015).
Together, these data lead us to suggest that both Plk1 and 
Aurora A contribute to the initiation of bipolar meiosis I spindle 
formation but that there is a greater requirement for Aurora A 
than Plk1 to promote timely onset of microtubule nucleation at 
NEBD. This, alongside our observations of diminished micro-
tubule growth upon down-regulating Plk4, suggests that Plk4 
and Aurora A cooperate to initiate microtubule nucleation, lead-
ing us to evaluate whether these kinases were associated with 
MTOCs. To determine whether the area of the spindle illumi-
nated by EGFP-labeled EB3 in these experiments reflects the 
distribution of total tubulin, we performed immunostaining of 
fixed preparations of oocytes to reveal α-tubulin after chemical 
inhibition of Aurora A or Plk4 kinases. This confirmed a com-
parable effect of the compounds on total α-tubulin levels thus 
validating spindle volume of EB3 fluorescence as an indicator 
of spindle size (Fig. S3). Consistent with previous findings 
(Saskova et al., 2008; Ding et al., 2011; Solc et al., 2012), we 
detected Aurora A at the MTOCs of mouse oocytes in its active 
phosphorylated form (pT288 Aurora A; Fig. 4 A). Additionally, 
Plk4 and Plk1 were also present at these MTOCs in meiosis I 
(Fig. 4, A and B; Solc et al., 2015). To assess how this reflects 
spatial activity of Aurora A, we examined the phosphorylation 
state of TACC3, an established substrate of Aurora A, which 
associates with the minus ends of microtubules on centrosomes 
(Barros et al., 2005; Kinoshita et al., 2005). Consistent with the 
localization of active (pT288) Aurora A on the MTOCs (Tyler 
et al., 2007) and in agreement with a previous study (Brunet 
et al., 2008), we detected pTACC3 at MTOCs, visualized with 
γ-tubulin. Importantly, the intensity of the pTACC3 signal was 
significantly reduced as a result of Aurora A inhibition (Fig. 4, 
C and F), but we were still able to detect pTACC3 at MTOCs 
after Plk4 inhibition, with a similar distribution as in control 
oocytes (Fig.  4, C and F). This suggests that Plk4 can regu-
late microtubule growth through pathways that do not involve 
Aurora A–mediated phosphorylation of TACC3. It seemed 
from these observations that the numbers of foci of pTACC3 
on microtubules were reduced significantly after the inhibition 
of Aurora A kinase, but not Plk4. To determine the effects of 
inhibiting either kinase upon cytoplasmic MTOCs, we treated 
oocytes with Aurora A or Plk4 inhibitors and stained them to 
reveal the centrosome components γ-tubulin, a component of 
the minus end–associated γ-tubulin ring complex; the γ-tubulin 
partner NEDD1; or the PCM-associated, Plk4 partner Cep192. 
Together, this revealed that inhibition of Aurora A, but not Plk4, 
led to a significant reduction in size and number of MTOCs 
(Fig. 4, D, E, G, and H). Thus, both Plk4 and Aurora A appear at 
MTOCs and in the vicinity of chromosomes, and at least some 
of their roles in initiating microtubule growth are independent 
of one another, with Aurora A being required for the correct 
distribution of MTOCs.
The requirement for Aurora A 
predominates over Plk4 to initiate 
microtubule nucleation
We next addressed the possibility for potential overlap in func-
tion of the two kinases by inhibiting both enzymes simultane-
ously and then determining the extent to which microtubule 
nucleation could be rescued by drug-resistant variants of either 
kinase alone or in combination. We could simultaneously in-
hibit both kinases by treating oocytes with either a combination 
extrusion under the different experimental conditions. After Aurora A inhibition by Aurora A inhibitor 1 (n = 21) or MLN8237 (n = 15), oocytes show a 
delay in establishment of a bipolar spindle compared with controls (n = 20), and they can undergo anaphase I without proper bivalent congression to the 
metaphase I plate. Under Plk4 inhibition by centrinone (n = 10), oocytes eventually form a bipolar spindle. Similarly, as a result of Plk1 inhibition using 
BI2536 (n = 15), oocytes exhibit a delay in establishing a metaphase plate, and anaphase onset is not observed within 17 h. (F) Prometaphase spindle 
length and width in controls (n = 23) compared with oocytes after inhibition of Plk1 (BI2536, n = 19), Plk4 (centrinone, n = 23), or Aurora A (Aurora A 
inhibitor 1, n = 22; and MLN8237, n = 11). Inhibition of each of the three kinases significantly decreases both prometaphase spindle length and width 
(***, P < 0.001). Error bars indicate SD of the mean. (G) Percentage of polar body extrusion (PBE) in control oocytes as well as after inhibition of Plk1 
(BI2536, n = 19), Plk4 (centrinone, n = 23), or Aurora A (Aurora A inhibitor 1, n = 22; and MLN8237, n = 11). Inhibition of Aurora A or Plk4 decreases 
the efficiency of polar body extrusion over 17 h of imaging. Inhibition of Plk1 completely prevents polar body extrusion within this time period.
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of Aurora A inhibitor 1 and centrinone (Fig. 5, B and H) or with 
the single inhibitory agent VX-680 (Fig. 5, C and H; Fig. S4; 
Table S3; and Video 3). VX-680 potently inhibits both Aurora 
A and Plk4 with nanomolar affinity because of conservation of 
amino acids that create the drug-binding site in the respective 
ATP-binding pockets (Scutt et al., 2009). In both cases, we ob-
served an enhanced inhibitory effect over the inhibition of indi-
vidual kinases (combined Aurora A Inhibitor 1 and centrinone, 
spindle size at 2 h: 29.8% of control; t502h = 72.7 ± 3.4 min; VX-
680, spindle size at 2 h: 16.1% of control; t502h = 78.1 ± 1.7 min; 
Table S2). However, VX-680 is also known to inhibit Aurora B 
and C kinases, which are highly similar in their ATP-binding 
sites (Tyler et al., 2007), resulting in a failure of cytokinesis and 
polar body extrusion (Yang et al., 2010). Despite the dramatic 
initial depression of microtubule nucleation by VX-680, it 
proved possible to rescue progression through mitosis and cyto-
kinesis phenotype resulting from Aurora B/C inhibition in 85% 
of VX-680–treated oocytes by expressing a VX-680–resistant 
mutant form of Aurora B (glycine 165 mutated to leucine, the 
murine equivalent of the human drug-resistant G160L mutant; 
Scutt et al., 2009; Fig. S4, H, I, and K–M). However, the Aurora 
B G165L mutant did not rescue the VX-680–mediated defects 
Figure 3. Aurora A, but not Plk1, is required for microtubule growth upon NEBD during mouse oocyte meiosis I. (A–D) Time-lapse series of mouse oocytes 
expressing EGFP-EB3 (green, top; gray, bottom) and histone H2B-mRFP (red, top). Depicted are controls (A), oocytes treated with 1 µM Aurora A inhibitor 
1 (AurA Inh 1; B) or 500 nM MLN8237 (C), and under Plk1 inhibition by treatment with 100 nM of the Plk1 inhibitor BI2536 (D). Time in hours :minutes 
relative to NEBD. (E) Quantification of the duration from NEBD to establishment of spindle bipolarity. Plk1 inhibition (BI2536) and Aurora A inhibition 
by Aurora A inhibitor 1 or MLN8237 significantly prolongs the time until establishment of a bipolar spindle (***, P < 0.001; *, P < 0.05) compared 
with controls (n = 20). Error bars indicate SD of mean. (F) Time from NEBD to establishment of a metaphase I plate until polar body extrusion (PBE). 
Plk1 and Aurora A inhibition significantly prolongs the time spent in metaphase. Additionally, Plk1 inhibition causes an arrest at metaphase I. The time 
spent in metaphase is significantly shorter for oocytes treated with Aurora A inhibitor 1 or MLN8237 than for controls (***, P < 0.001; **, P < 0.01; 
*, P < 0.05). Error bars indicate SD of mean. (G) Measurement of the size of projected spindle area throughout time. Inhibition of Aurora A (AurA Inh 1, 
n = 21; MLN8237, n = 5) or Plk1 (BI2536, n = 15) significantly reduces the spindle size reached at 2 h; however, the kinetics of microtubule growth is only 
affected by inhibition of Aurora A. For p-values and t502h, see Tables S1 and S3, respectively. Time 00:00 corresponds to time of NEBD and is determined 
by invasion of the EGFP-EB3 signal within the area previously occupied by the nucleus. Error bars indicate SEM. See also Video 2.
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Figure 4. Aurora A activity is required for the correct size and number of MTOCs in oocytes. (A) Localization of Plk4 and Aurora A phosphorylated at thre-
onine residue 288 (AurApT288) revealed by immunostaining of oocytes with anti–Plk4 (red), anti–α-tubulin (green), and anti–AurApT288 (red) antibodies. 
Separated channels in gray are also shown as indicated; DNA is shown in blue. Both kinases colocalize at MTOCs. (B) Localization of PlK1 at MTOCs 
revealed by immunostaining of meiosis I oocytes with anti-Plk1 (red) and anti–α-tubulin (green). Plk1 and Plk4 channels are also shown in monochrome and 
DNA in blue. (C) Meiosis I oocytes stained to visualize DNA (blue), γ-tubulin (red), and phospho-TACC3 (pTACC3, green; top) or α-tubulin (red, middle) and 
pTACC3 (monochrome, bottom). Depicted are controls compared with conditions in which Aurora A and Plk4 were inhibited by treatment with Aurora A in-
hibitor 1 or centrinone, respectively. Aurora A inhibition causes a significant reduction of pTACC3 at MTOCs (see bottom panel, pTACC3 in monochrome). 
(D) Oocytes stained with antibodies against α−tubulin (gray, bottom), DNA (blue, top), γ-tubulin (red or monochrome), and CEP192 (green or monochrome, 
bottom; A) or stained to visualize α−tubulin (gray, top), DNA (blue, top), γ-tubulin (red or monochrome), and NEDD1 (green or monochrome, bottom; E). 
Shown are representative images of controls and of oocytes treated with Aurora A inhibitor 1 and centrinone. Bars, 10 µm. (F) Measurement of pTACC3 
pixel intensity at the MTOCs relative to the background (*, P < 0.05). Error bars represent SD of the mean. (G and H) Quantifications of the size (G) 
and number (H) of γ-tubulin–positive MTOCs. Aurora A inhibition, but not treatment of oocytes with the Plk4 inhibitor centrinone, causes a significant 
reduction in size and number of MTOCs (**, P < 0.01).
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in microtubule growth around chromatin in the first hour after 
NEBD, strongly suggesting that these events must arise as a 
result of the inhibition of kinases other than Aurora B (Fig. S4, 
I and K–M). Because Aurora C is so similar to Aurora B in 
terms of drug-binding site, sensitivity to inhibitors, subcellular 
localization, and functions in late M phase and cytokinesis, it is 
unlikely to be involved in these early events. VX-680 is also a 
known inhibitor of several tyrosine kinases (Scutt et al., 2009). 
Therefore, we tested the consequences of treating oocytes with 
saracatinib (Chang et al., 2008), which interferes with the activ-
ity of Src kinase and a similar group of tyrosine kinases that are 
also sensitive to VX-680. We found that the initial nucleation 
of microtubules after saracatinib treatment was indistinguish-
able from controls, indicating that saracatinib-sensitive tyrosine 
kinases do not contribute to this process (Fig. S5, F, G, and J). 
Thus, the dual inhibition of Aurora A and Plk4 resulting from 
VX-680 treatment is likely to contribute significantly the delay 
in microtubule growth after NEBD.
To determine whether Plk4 and Aurora A show any inter-
dependency for the initiation of microtubule growth after re-
sumption of meiosis, we inhibited both kinases simultaneously 
using VX-680 (Fig. 5 C) and then exploited chemical genetics 
to investigate whether individual drug-resistant alleles of either 
kinase could overcome the inhibition when expressed exoge-
nously in oocytes. Activity-sparing VX-680–resistant point 
mutants in the ATP-binding pocket of Aurora A have been 
previously described (Scutt et al., 2009; Sloane et al., 2010). 
We found that expression of the mouse counterpart of inhibi-
tor resistant Aurora A (G229L) in VX-680–treated oocytes was 
sufficient to restore 44.9% of spindle volume 2 h post-NEBD 
(compared with 16.1% of controls after VX-680 treatment 
alone; Fig. 5, E and I). Expression of drug-resistant Aurora A 
also greatly restored the time to attain half the level of microtu-
bule nucleation (t502h of spindle formation of 63 ± 2.5 min com-
pared with 78.1 ± 1.7 min after VX-680 treatment alone; Fig. 5, 
E and I; Table S2; and Video  3). In contrast, a kinase-dead 
variant of Aurora A G229L was unable to restore microtubule 
growth and indeed had a dominant-negative effect (t502h = 93.8 
± 7.4 min; Fig. 5, F and I; and Table S2), confirming a require-
ment for Aurora A catalytic activity for rescue. Expression of 
an inhibitor-resistant Plk4 allele (G95R) in VX-680–treated 
oocytes gave little rescue of the delay in microtubule growth 
(t502h = 66.6 ± 4.9 min; Fig. 5, D and I; and Table S2) and was 
unable to restore spindle size (Fig. 5, D and I). However, co-
expression of both Plk4 G95R and Aurora A G229L enhanced 
the rescue of spindle size to 55%, which is beyond that given 
by expression of drug-resistant enzyme Aurora A G229L alone 
(Fig.  5, G and J; and Video  3). Their expression also further 
reduced the time for attaining 50% of spindle size at 2 h (t502h 
= 47.9 ± 2 min; Fig.  5, G and J; and Table S2). Thus, Plk4 
appears able to influence the kinetics of the initial microtubule 
nucleation within limits set by Aurora A activity. The inabil-
ity to achieve complete rescue of VX-680 inhibition with these 
mutant kinases may reflect an inherent limitation of the func-
tion of these mutant enzymes in vivo, or it could indicate the 
involvement of another kinase in microtubule nucleation that is 
inhibited by VX-680. Nevertheless, our experiments do point 
to a substantial involvement of Aurora A in initiating spindle 
formation. Moreover, the ability of drug-resistant Plk4 to en-
hance the rescue of VX-680 inhibition by drug-resistant Aurora 
A while being poorly able to do so alone suggests a set of Plk4 
functions that are dependent on Aurora A.
These findings led us to ask whether Plk4’s role in micro-
tubule nucleation might be dependent on Aurora A. To address 
this, we investigated whether Aurora A or Plk4 could phosphor-
ylate or regulate each other’s catalytic activity in vitro using the 
highly conserved human Plk4 and Aurora A kinases that (like 
their mouse counterparts) become resistant to VX-680 when 
they carry G95R (Plk4) and G216L (Aurora A) substitutions 
(Fig. S5 A). Although Aurora A was unable to phosphorylate 
Plk4 (Fig. S5, B and F–K), Plk4 could phosphorylate Aurora 
A at T288, the key regulatory site for vertebrate Aurora A ac-
tivation (Scutt et al., 2009; Sloane et al., 2010). This phospho 
site was identified by Western blotting with a phosphospecific 
pT288 Aurora A antibody (Fig. S5 C) and also by mass spec-
trometry (Fig. S5, F–K). Critically, we found that dephosphor-
ylated (low-activity) Aurora A was reactivated by incubation 
with catalytically active Plk4 (but not kinase-dead D154A Plk4) 
nearly as efficiently as it was by TPX2 (Fig. S5 D), an allosteric 
activator of Aurora A (Eyers et al., 2003). Consistently, we 
also observed that preincubation with Plk4 and ATP led to a 
time-dependent increase in Aurora A activity (Fig. S5 E). Thus, 
although Plk4 and Aurora A can have independent targets, these 
experiments suggest that the enhancement of Aurora A function 
in the oocyte could in part be explained through concerted ac-
tivation of Aurora A by Plk4. This is unlikely to be the whole 
story, however, because TACC3 phosphorylation is reduced 
after inhibition of Aurora A, but not Plk4 (Fig. 4, A and F), This 
suggests that the two kinases might participate in distinct reg-
ulatory pathways. It also implies that Aurora A is autoactivated 
or activated by kinases or cofactors that are distinct from Plk4 
in vivo (see Fig. 10). Collectively, our findings suggest that both 
Plk4 and Aurora A have independent and interdependent roles 
at MTOCs and in the vicinity of chromosomes to nucleate mi-
crotubules and initiate spindle formation.
Aurora A, Plk4, and Ran-GTP differentially 
control microtubule growth
Our findings suggested that Aurora A and Plk4 could together 
contribute to microtubule nucleation in the oocyte in addition 
to Ran. This led us to compare the effects of inhibiting these 
three pathways. As before, we used Aurora A inhibitor 1 and 
centrinone to inhibit Aurora A and Plk4 protein kinases, and we 
suppressed the Ran pathway using dominant-negative (T24N) 
Ran. We found that all three treatments led to a similar reduc-
tion of microtubule nucleation in the 2-h interval after NEBD 
(Fig.  6, A–E). However, notably distinct from kinase inhibi-
tion, Ran T24N led to loss of spindle pole integrity (Fig. 6 F) 
and also resulted in a significant delay in the establishment 
of spindle bipolarity (Fig. 6 G). This suggests that in addition 
to the initial diminution of microtubule density after NEBD, 
the Ran pathway might have other functions beyond those 
of Aurora A and Plk4 that could possibly reflect other down-
stream effectors of Ran-GTP.
We then asked whether expression of the gain-of-function 
mutant Ran Q69L might overcome the effects of inhibiting ei-
ther Aurora A or Plk4. By itself, Ran Q69L led to an increase in 
projected spindle area, in accord with Ran’s effect on microtu-
bule density (Fig. 7, A, D, and G; and Video 4), but was unable 
to overcome the delay in microtubule nucleation in the 30 min 
after inhibition of either Aurora A or Plk4. However, once some 
microtubules had formed, Ran Q69L promoted an increase in 
microtubule growth to levels above those of untreated control 
oocytes (Fig. 7, A and D; and Video 4). The effects of inhibiting 
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Figure 5. Requirement for Aurora A predominates over Plk4 to initiate microtubule nucleation. (A–G) Time-lapse series of oocytes injected with mRNA encoding 
EGFP-EB3 (green, top; inverted, bottom) and H2B-mRFP (red, top). Progression through meiosis I was followed in controls (A) and under simultaneous inhibition of 
Aurora A and Plk4 by a combination of Aurora A inhibitor 1 and centrinone (B) and treatment with 1 µM VX-680 (C). To assess reversion of the defects in microtu-
bule growth caused by VX-680, oocytes were coinjected with mRNAs for the Plk4 point mutant G95R (D), Aurora A G229L (E), kinase-dead Aurora A G229 (F), 
and both Aurora A G229L and Plk4 G95R (G). (H–J) Quantifications of the size of the projected spindle area over time. (H) Compared with single kinase inhibition 
(AurA Inh1, n = 33; centrinone, n = 22), treatment with Aurora A inhibitor 1 and centrinone in combination (AurA Inh1 + centrinone, n = 10) and VX-680 (n = 26) 
further depresses microtubule growth. (I) Defects caused by VX-680 are not restored by kinase-dead Aurora A G229L (n = 9), partially rescued by expression of 
Plk4 G95R (n = 10), and significantly restored by expression of inhibitor-resistant Aurora A G229L (n = 15). (J) Rescue by Aurora A G229L is enhanced when Plk4 
G95R is coexpressed (n = 14). Error bars indicate SEM (***, P < 0.001; **P < 0.01; *P < 0.05). See also Tables S1 and S2 and Video 3.
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either kinase combined with the expression dominant-negative 
Ran T24N was additive and resulted in greatly diminished mi-
crotubule nucleation after NEBD (Fig. 7, A, B, D, E, and G; and 
Video 4). Together, these data suggest that Ran is able to play a 
role beyond that of Aurora A and Plk4 in initiating microtubule 
nucleation after the resumption of female meiosis.
As an alternative approach to monitoring the effects of in-
hibiting the Aurora A, Plk4, and Ran pathways, we followed the 
movement of chromosomes, which is mainly promoted by mi-
crotubule growth in the earliest steps of spindle formation. We 
could distinguish three broad dynamic phases of chromosome 
movement: (1) an inward movement within the first 30–45 min 
of NEBD as condensing chromosomes collapsed onto each 
other when there is very little microtubule growth, (2) an out-
ward expansion of the chromosomes that occurs between 45 
min and 2 h:30 min after NEBD, and (3) the onset of chromo-
some congression onto the metaphase plate (Fig. 8 A). Because 
the outward expansion process represents chromosomes being 
forced apart by the increase in number and length of growing 
microtubules, we focused on this specific phase.
Our movies (Fig. 8 A) indicated that the extent and ve-
locity of movement was decreased upon inhibition of either 
Aurora A or Plk4 (Fig.  8, A, B, and D), and this was more 
pronounced when both kinases were inhibited simultaneously 
by VX-680. Chromosome expansion was least affected by the 
dominant-negative Ran T24N mutant. We also observed that 
Aurora A inhibition appeared to allow chromosomes to adopt a 
bipolar pattern of movement (Fig. 8, B and D). To assess further 
this directionality of movement, we represented the distribution 
of the 2D coordinates of chromosomes within an ellipse (Fig. 8, 
C and E). The relative mean dimensions of the axes of such 
ellipses indicate that inhibition of Plk4 or Aurora A reduced 
chromosome expansion to a similar extent that appeared addi-
tive on dual inhibition. The axial ratio of the ellipses indicated 
that chromosomes expand as a spherical ball in control oocytes 
and after Plk4 inhibition but more elliptically after Aurora A 
Figure 6. Ran, Plk4, and Aurora A cooperate to promote bipolar spindle assembly. (A–D) Time-lapse series of oocytes injected with mRNA encoding 
EGFP-EB3 (green, top; inverted monochrome, bottom) and H2B-mRFP (red, top). Progression through meiosis I is shown for controls (A), oocytes treated 
with 1 µM Aurora A inhibitor 1 (AurA Inh 1; B), oocytes imaged in the presence of 2 µM of the Plk4 inhibitor centrinone (C), and oocytes coinjected with 
RanT24N-mRFP (D). (E) Quantification of the size of the projected spindle area over time. RanT24N, Plk4, and Aurora A alone each contribute to meiotic 
spindle assembly, because their inhibition causes significantly reduced microtubule growth. Error bars indicate SEM. For p-values, see Table S1. (F) Stills of 
time-lapse movies showing metaphase spindles in oocytes undergoing meiosis I in conditions described in A–D. RanT24N, as opposed to Aurora A or Plk4 
inhibition, affects spindle pole integrity (arrowheads). (G) Compared with Aurora A and Plk4 inhibition, dominant-negative Ran (RanT24N) significantly 
increases the time taken to establish bipolarity. Error bars indicate SEM.
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Figure 7. Ran has distinct functions from Aurora A and Plk4 during assembly of a meiosis I spindle. (A) Time-lapse imaging of oocytes injected with EGFP-EB3 
(black, inverted) and histone H2B-mRFP (red) mRNAs. Shown are controls and oocytes treated with 1 µM Aurora A inhibitor 1 or 2 µM centrinone. For each con-
dition, oocytes were additionally injected with mRNA encoding dominant-negative RanT24N-mRFP or constitutively active RanQ69L-mRFP. (B–G) Size of projected 
spindle areas. In untreated control conditions, RanQ69L expression (D and G; n = 22) significantly increases EGFP intensities, whereas RanT24N (C and F; n = 
18) decreases these values compared with controls (n = 44). Compared with oocytes treated with Aurora A inhibitor 1 (AurA Inh 1) alone (B–D; n = 21), RanT24N 
in the presence of Aurora A inhibitor 1 (B and C; n = 13) causes a further reduction in the projected spindle area; RanQ69L (D; n = 13) is not able to significantly 
rescue these defects. Under inhibition of Plk4 by centrinone treatment (E–G; n = 23), RanT24N (E and F; n = 12) induces a further depression of quantified spindle 
area throughout time; RanQ69L (G; n = 13) leads to an increase of these values at later time points. Error bars indicate SEM. See also Video 4.
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Figure 8. Cooperation among Ran, Aurora A, and Plk4 in regulating bivalent movement and congression toward the metaphase I plate. (A) Time-lapse imag-
ing of oocytes expressing histone H2B-mRFP (inverted, black). Shown are the first 4 h of meiosis I after NEBD for controls; oocytes treated with 2 µM centrinone, 
1 µM Aurora A inhibitor 1 (AurA Inh 1), or 1 µM VX-680; and oocytes expressing dominant-negative RanT24N. Three phases of chromosome movement 
(collapse, outward expansion, and bivalent congression) are indicated. (B) Representative chromosome tracks of the outward expansion for each indicated 
condition. Directionality and distance of movement is represented by the angle and length of the arrows, respectively; arrow thicknesses illustrate speeds. 
(C) Schematic representation of chromosome distributions at their maximum expansion, as quantified in E. Mean values for major and minor axes for each 
condition are shown (±SEM). (D) Violin plots depicting the frequency distribution of mean velocity of chromosome movements, which is significantly reduced as 
a result of Plk4 and Aurora A inhibition. (E) Fitting of the chromosome end coordinates at their maximal expansion to an ellipse. Control, RanT24N-expressing, 
and centrinone-treated samples display an isotropic distribution of chromosomes that tends to a 2D circle (ratio between major and minor axis approximates 
1). In oocytes treated with Aurora A inhibitor 1 or VX-680, chromosomes show a preferential expansion direction along the axis of spindle, indicated by a ratio 
between major and minor axis of the fitted ellipse that is higher than 1 and significantly differs from the control (see Materials and methods; ***, P < 0.001).
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inhibition (Fig. 8, C and E). This difference in expansion pattern 
of the chromosome mass after inhibition of Aurora A accords 
with a role for Aurora A in the promotion of microtubule growth 
around chromatin and a need for Aurora A activity to establish 
the correct number and size of MTOCs (Fig. 4).
The pattern of chromosome movement after disrup-
tion of the Ran pathway indicated that the dominant-negative 
RanT24N did not reduce the velocity of the outward expansion 
of the chromosome mass at NEBD to the same extent as Aurora 
A inhibitor 1 and centrinone. Down-regulation of Ran function 
also had little effect on the spherical organization of the chro-
mosome mass as it expanded in comparison to inhibition of 
Aurora A (Fig. 8, C and E). This points toward an independent 
function of the Ran pathway, as previously suggested.
To gain insight into whether the different effects of inhib-
iting Aurora A, Plk4 or Ran might affect microtubule stability 
or nucleation, we assessed FRAP under these three conditions 
in oocytes expressing EB3-EGFP. We classified oocytes resum-
ing meiosis I into three different stages (1–3; Fig. 9 A), as we 
did when assessing chromosome movement previously, and 
simultaneously bleached EB3 fluorescence both close to cyto-
plasmic MTOCs and in the vicinity of chromosomes (Fig. 9 A). 
We then followed fluorescence recovery in these two regions of 
interest (ROIs; 1 and 2).
The striking feature of stage 1 was that the recovery of 
fluorescence in the regions of cytoplasmic MTOCs fluorescence 
was only ∼50% if Aurora A was inhibited. This indicates a 
higher immobile population of EB3 compared with either con-
trol oocytes (60%) or those treated to inhibit Plk4 or Ran. A 
higher immobile population suggests that microtubules growing 
from cytoplasmic MTOCs are less dynamic after Aurora A inhi-
bition at this very early stage (Figs. 9 B and Table S4). This ef-
fect of Aurora inhibition was not seen in stage 2 between 45 min 
and 2 h:30 min after NEBD, when the most pronounced effect 
was a slowing of the rate of fluorescence recovery after expres-
sion of dominant-negative Ran or Plk4. As the bipolar spindle 
began to form in stage 3, there were no significant differences 
in fluorescence recovery around cytoplasmic MTOCs in control 
oocytes or oocytes that had received any of the three treatments.
In assessing fluorescence recovery in the vicinity of chro-
matin, we saw little effect of the inhibitory treatments during 
stage 1.  However, as microtubules adopted a ball-shaped ar-
rangement in stage 2, all treatments led to an increased mobile 
fraction relative to untreated oocytes after Ran or Plk4 inhibi-
tion. This suggests destabilization and increased dynamicity of 
microtubule plus tips by these treatments. In addition, an effect 
upon the t1/2 for fluorescence recovery after all treatments sug-
gests all three pathways are required for microtubule growth. 
An increase in t1/2 after Ran and Plk4 inhibition indicates the 
requirement of these two pathways to promote microtubule 
growth around chromatin. In stage 3, by the time bipolarity be-
gins to be established, an increase in the mobile fraction around 
chromatin was seen after Aurora A or Plk4 inhibition and the 
loss of Ran function continued to depress the kinetics of fluo-
rescence recovery, confirming its continued requirement to pro-
mote microtubule growth around chromatin and MTOCs.
Together, these findings point to distinct roles for Plk4, 
Aurora A, and Ran in directing the initial growth of microtu-
bules upon meiotic resumption. The most pronounced effect of 
Aurora A inhibition was to reduce the dynamicity of microtu-
bules around cytoplasmic MTOCs immediately after NEBD. 
Plk4 inhibition, on the other hand, led to loss of stability of 
microtubules in the vicinity of chromatin, particularly when 
microtubules were present as a ball-like mass. Inhibition of 
the Ran pathway depressed the growth of all microtubules but 
particularly in the vicinity of chromatin and as the bipolar spin-
dle began to form. Such kinetics of fluorescence recovery in 
oocytes expressing dominant-negative Ran accord with a role 
for Ran in promoting microtubule growth after NEBD as found 
by Schuh and Ellenberg (2007) and point to Ran-GTP having 
cooperative but distinct roles from those of Aurora A and PLk4 
in the initiation of spindle assembly in the oocyte.
Discussion
Although the gradient of Ran-GTP around chromatin is crit-
ical to promote spindle formation in the absence of centro-
somes in many systems (O’Connell and Khodjakov, 2007), it 
is not essential for formation of the first bipolar meiotic spindle 
upon meiotic resumption in the acentriolar mouse oocyte, even 
though it does contribute to the increase in density of microtu-
bules after NEBD (Dumont et al., 2007; Schuh and Ellenberg, 
2007). By analyzing the very first events in spindle formation 
upon NEBD, we find that two protein kinases, Aurora A and 
Plk4, both contribute to trigger microtubule growth and forma-
tion of the first meiotic spindle. Inhibition of either kinase dra-
matically reduces microtubule growth, leading to a reduction 
in the velocity of the outward expanding chromosomes that are 
pushed apart by nascent microtubules as the spindle forms. Plk4 
inhibition diminishes microtubule growth upon resumption of 
meiosis, but bipolar spindle formation does eventually occur 
in a process that requires Aurora A, but not Plk1. The specific 
defects associated with the inactivation of Plk4 or Aurora A 
suggest that they have both independent and overlapping roles.
Independent functions of the two kinases are reflected in 
the different effects of their inhibition upon the organization 
of MTOCs, upon the expansion pattern of chromosomes after 
NEBD, and upon the recovery of fluorescence of a microtu-
bule plus tip–associated protein after photobleaching. Together, 
these findings suggest that the two kinases affect microtubule 
growth in different ways. In the 30–45 min after NEBD, in-
hibition of either kinase severely reduces microtubule growth, 
but Aurora A inhibition also results in cytoplasmic MTOCs that 
are reduced in both size and number. The reduced recovery of 
EB3-GFP fluorescence after photobleaching in the vicinity of 
the cytoplasmic MTCs after Aurora A inhibition also suggests a 
loss of dynamicity of the nucleated microtubules not seen after 
Plk4 inhibition. Similarly the expansion of chromosomes asso-
ciated with a growing ball of microtubules between 45 min and 
2 h and 30 min after NEBD is greatly reduced by inhibition of 
either kinase. However, again the effect of Aurora A inhibition 
appears greater and results in a more pronounced bidirectional 
movement of chromosomes. This may reflect greater ease in 
establishing bipolarity from a reduced number of cytoplasmic 
MTOCs after Aurora A inhibition. In contrast, Plk4 inhibition 
leads to greater dynamicity of microtubules in the vicinity of 
chromosomes than does Aurora A inhibition.
The overlapping functions of the two kinases are indi-
cated by the extent to which their drug-resistant variants can 
rescue the effects of their simultaneous inhibition by VX-680, 
a drug that almost completely suppresses microtubule growth 
after NEBD. This phenotype is substantially rescued by a 
drug-resistant form of Aurora A, but not by drug-resistant Plk4 
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Figure 9. Temporal and spatial analysis of Aurora, Plk4 and RAN in the early steps of microtubule growth and dynamics. (A) Representative time-lapse 
images of oocytes injected with EGFP-EB3 (green) and histone H2B-mRFP (red) mRNAs showing the three different stages after oocyte meiosis I resumption 
under four experimental conditions: standard control conditions, Plk4 inhibition by addition of 2 µM centrinone, Aurora A inhibition by addition of 1 µM 
Aurora A inhibitor I, and Ran pathway inhibition by coexpression of the RanDN-negative form RanT24N. Regions of interest (ROIs) are indicated in the 
image, where ROI 1 is marking a cytoplasmic MTOC and ROI 2 a chromosomal MTOC typically bleached and analyzed by FRAP. Stage 1 occurs immedi-
ately after NEBD for a period of 30–45 min, during which time microtubules emanating from cytoplasmic MTOCs and around chromosomes are observed. 
Stage 2 comprises the time when microtubule density increases adopting a round ball-like shape. Stage 3 is the early phase of bipolarization when the 
spindle begins to elongate and MTOCs cluster toward the poles. Bars, 10 µm. (B) Graphs show the nonlinear fit curve for EB3-EGFP fluorescence intensity 
after bleaching (see Materials and methods for details) in oocytes after meiosis resumption under the different experimental conditions through the three 
stages described in A. Time after photobleaching is indicated as t = 0 s Fluorescence recovery and t1/2 were determined by applying a single exponential 
fitting to the recovery curve. Time is given in seconds. Each curve represents the mean value and 95% confidence interval. The 95% confidence interval 
for mobile fraction and t1/2 are shown below each graph. Plot of mean of values for each dataset at the three different stages are also shown. Error bar 
represents SEM. See also Table S4. These samples were both tested for normally distributed (D’Agostino–Pearson) and nonparametric tests (Wilcoxon 
matched pair test). In both cases, the null hypothesis was rejected (***, P < 0.001).
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alone. However, drug-resistant Plk4 can enhance the rescuing 
ability of drug-resistant Aurora A upon combined inhibition of 
the two endogenous kinases. This suggests that in addition to 
having independent functions, a subset of Plk4 functions might 
be dependent on Aurora A. This hypothesis is supported by the 
finding that Plk4 is able to phosphorylate Aurora A at T288 in 
its T-loop and is so able to potentiate its function (Fig. S5). The 
sequence surrounding T288 in the Aurora A activation segment 
conforms to a relaxed Plk4 substrate consensus and differs 
markedly from the acidic context required for Plk1–3 phosphor-
ylation (Johnson et al., 2007). This is suggestive of a potential 
role for Plk4 in Aurora A regulation.
We also find a decrease in microtubule growth after 
NEBD after inhibition of the Ran pathway that accords with 
the findings of Schuh and Ellenberg (2007). The diminution of 
microtubule growth after inhibition of either Aurora A or Plk4 
is accentuated by dominant-negative Ran but not rescued by 
constitutively active Ran. This suggests that the kinases and the 
Ran pathway function interdependently. The recovery of FRAP 
microtubule plus tip–associated EB3-GFP suggests that Ran 
is required for the kinetics of microtubule growth, particularly 
around cytoplasmic MTOCs as the microtubule ball expands 
and in the vicinity of chromatin as the bipolar spindle forms. 
Thus, although Ran is not required for bipolar spindle forma-
tion (Dumont et al., 2007), our findings provide support for its 
role in promoting microtubule growth (Schuh and Ellenberg, 
2007) after NEBD and would accord with a role in releasing 
microtubule-associated proteins such TPX2 to promote micro-
tubule stabilization at later stages (Brunet et al., 2008).
In contrast to the similar phenotypes that result from Au-
rora A or Plk4 inhibition in the oocyte, the consequences of 
inhibition of these kinases in the acentriolar mouse embryo 
are quite different. Notably, depletion of Plk4, expression of 
dominant-negative forms, or centrinone treatment in the acen-
triolar embryo (Fig. S1) result in a severe delay of microtu-
bule nucleation, monopolar spindle formation, and cytokinesis 
defects (Coelho et al., 2013), whereas inhibition of Aurora A 
has only a slight effect on spindle size (Fig. S1). These dif-
ferences between the oocyte and the embryo might reflect the 
profoundly different aspects of cell cycle regulation in these 
two acentriolar cell types. The prolonged nature of meiosis I 
with gradual activation of Cdk1 (Brunet and Maro, 2005) con-
trasts with the extremely rapid activation of Cdk1 during mito-
sis and meiosis II. As the dynamic instability of microtubules 
responds to Cdk1 activity, a dual requirement for cooperative 
Aurora A and Plk4 activities to initiate spindle formation 
could represent a conserved “fail-safe” mechanism to ensure 
rapid microtubule growth in the window of low Cdk1/cyclin B 
activity upon meiotic resumption.
In conclusion, we have identified Aurora A and Plk4 as 
protein kinases that act in concert with Ran to trigger rapid 
growth of microtubules to allow the assembly of a robust acen-
trosomal meiosis I spindle. Interestingly, Aurora A appears able 
to act as a potential Plk4 effector. However, it would seem that 
Plk4 has additional, currently unknown substrates that account 
for its functions that are independent of Aurora A. We antici-
pate that Aurora A can also be activated by other mechanisms in 
oocytes resuming meiosis. Indeed, we have identified TACC3, 
known to contribute to the activation of Aurora A, as one of 
Aurora A’s early targets at MTOCs (Fig. 10). The existence of 
multiple mechanisms for initiating spindle formation in the oo-
cyte in the absence of centrosomes points to the critical need 
to safeguard the equitable transmission of chromosomes to the 
next generation, arguably the single-most important cell divi-
sion in the vertebrate life cycle.
Materials and methods
Oocyte and embryo collection and culture
Oocytes were collected from 4- to 8-wk-old F1 females and recov-
ered from tertiary follicles as previously described (Wianny and 
Zernicka-Goetz, 2000). Isolated oocytes were cultured under mineral 
oil in M2 media supplemented with 1 µM dbc-AMP (Sigma) to pre-
vent meiotic maturation. During time-lapse imaging, oocytes were 
cultured in M16 medium (Sigma) without dbc-AMP at 37°C in a 5% 
CO2 atmosphere. For embryo microinjections, C57BL6 × CBA mice 
were mated after superovulation of females, and embryos were col-
lected in M2 media following previously described standard proce-
dures (Piotrowska-Nitsche et al., 2005; Bischoff et al., 2008). Isolated 
embryos were cultured in KSOM media under paraffin oil at 37°C in 
a 5% CO2 atmosphere. For the purpose of inhibitor studies, the media 
was supplemented with inhibitors at the following concentrations: 500 
nM for MLN8237 (SelleckChem), 100 nM for BI2536 (SelleckChem), 
1–5 µM for Aurora A inhibitor 1 (SelleckChem), 2–5 µM for centri-
none (provided by Y. Liang Wong and K. Oegema, Ludwig Institute for 
Cancer Research, University of California, San Diego, San Diego, CA, 
and by T.C. Gahman and A.K. Shiau, Ludwig Institute for Cancer Re-
search, San Diego, CA; described in Wong et al., 2015), 0.5–5 µM for 
VX-680, and 1 µM for saracatinib (Table S3). All experimentation with 
mice was performed following requirements of the UK Home Office 
under a project license held by M. Zernicka-Goetz.
Microinjections
For microinjection of mRNA, in vitro transcription of Sfil-linearized 
RN3P plasmids was performed using mMessage mMachine T3 Poly-
merase (Life Technologies) according to the manufacturer’s instruc-
tions. Nhe1-linearized pGEM plasmid was in vitro transcribed using 
mMessage mMachine T7 Polymerase (Life Technologies). Microin-
jection of in vitro transcribed mRNAs was performed as previously 
established (Zernicka-Goetz et al., 1997). After injection, oocytes were 
left for 3–4 h before imaging. For microinjections of embryos, a single 
random blastomere was microinjected with the RNAs to monitor cell 
division at the two-cell stage.
Live cell imaging and image analysis
Oocytes released from prophase arrest were selected manually, and 
only those oocytes included that harbored a surrounded nucleolus con-
figuration (Zuccotti et al., 2005). NEBD was established as the time 
00:00, as the time when EB3-GFP signal was first observed inside the 
nucleus, corresponding to the NEBD. Prometaphase I comprises this 
period until metaphase I, when bivalents assume an aligned position 
at the equatorial plate. At metaphase I, the distance between spindle 
poles is also reduced until the onset of anaphase I. This criterion was 
also used to help defining this stage. Cytokinesis I is defined when ex-
trusion of the polar body is detected. Time-lapse images were collected 
every 15 min over the course of 20 h for the green and red channels on 
an inverted Zeiss Axiovert with a spinning disk confocal head (Intelli-
gent Imaging Solutions) using a 63×/1.3 water objective. Each Z stack 
comprises 20 images at 3-µm intervals. Acquisition was performed 
using Slidebook software 6.0.0.20. Images were converted to 16-bit 
TIFF file format using ImageJ, and all image analysis was performed 
with the custom algorithms available in ImageJ analysis software 
(Schneider et al., 2012).
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Quantitation of total α-tubulin by immunofluorescence indi-
cated measurement of the space occupied by EGFP-EB3 to provide 
a suitable way of assessing spindle growth after centrinone inhi-
bition of Plk4 (Fig. S4).
Detection of chromosomes, measurement of x–y coordinates for 
each time frame, and the mean speed of chromosome movement was 
performed using TrackMate plugin. Time frames that corresponded to 
the outward expansion were manually selected. The outward-expan-
sion process was followed for 2 h, and only tracks that detected chro-
mosomes for five to nine frames were included in the analysis. For EB3 
intensity measurements, ROIs corresponding to the spindle area were 
manually selected. Pixel intensity in the spindle area and in an equiva-
lent area in the cytoplasm (background fluorescence) were determined. 
The size of the spindle area was determined after image thresholding.
Data preprocessing
Spindle-area data and EB3 intensity quantifications were initially cor-
rected by subtracting background values. Time-course data were normal-
ized to the first time point by subtracting the first value (time zero) from 
all other time point measurements. Resulting data for EB3 intensity and 
spindle area were plotted as mean ± SEM (error bars) for each time point.
Statistical comparison between different conditions in each time point
For the pairwise comparison in each time point, we considered the 
set of preprocessed measurements of the two conditions to compare 
(i.e., control vs. condition, or two different conditions), and we as-
sessed whether the difference was significant using the two-sided 
Wilcoxon rank-sum test.
Analysis of spindle expansion kinetics
To describe the kinetics of microtubule and spindle growth in the dif-
ferent conditions, we assumed that spindle expansion follows a sig-
moidal-shaped curve. The preprocessed EB3 intensity and spindle 
area quantifications were fitted to sigmoid curves using the following 
four-parameter logistic function:
  y =  A 1 +  
 A 2​−​​A 1  ____________  1 +  10  ( t50−x ) ∗.slope , (1)
where t50 represents the time when the spindle reaches the 50% of its maxi-
mal expansion and slope represents the velocity of such a process (t502h).
The parameter vectors used to initialize the fitting procedure 
were [A1, A2, t50, slope] = [min(datacondition), max(datacondition), 40, 0]. 
The estimation of parameters that best fit the nonlinear regression rela-
tive to each experimental condition was performed using the MAT LAB 
iterative least-squares estimation routine.
To evaluate differences in the global kinetics of the process, we 
compared t502h and the relative intervals of confidence at 95% estimated 
during the fitting of Eq. 1. Expansions with t502h and relative intervals 
of confidence completely disjoint were considered statistically differ-
ent. For p-values and t502h values, see Tables S1 and S2, respectively.
Analysis of the maximal spindle expansion pattern
We assumed spindle expansion is an isotropic process. The different 
conditions examined reduced spindle progression and expansion, re-
sulting in a final anisotropic distribution of chromosomes at the max-
imal spindle expansion. To evaluate quantitatively such aspect in each 
individual experiment, we considered all quantifications relative to the 
Figure 10. Meiosis I spindle formation is a result of Aurora A, Plk4, and Ran-GTP activity. Spindle assembly in the oocyte is a multistep process triggered 
by the cooperative activity of Plk4 (yellow) and Aurora A (red), which are essential to initiate microtubule growth at NEBD. Plk4 and Aurora A localize to 
MTOCs that are dispersed around condensed chromosomes. Aurora A activity is potentiated by Plk4, directly phosphorylating the kinase at five Ser/Thr 
residues including the T-loop activating site, but likely undergoing additional regulation by meiotic kinases and/or regulatory binding partners. Both Aurora 
A and Plk4 can have a distinct and shared set of substrates. We identify TACC3 as one potential downstream effector of Aurora A that localizes to MTOCs 
and whose phosphorylation is reduced upon Aurora A inhibition (see Fig. 4 C). Other pathways are likely acting at later stages of spindle assembly and 
are able to partially overcome the defects caused by inhibition of Aurora A and Plk4. One redundant pathway is Ran-GTP, which, by increasing levels of 
the allosteric Aurora A activator TPX2, is important for TACC3-mediated microtubule stabilization at the spindle poles.
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final and maximal spindle expansion in terms of chromosome 2D coor-
dinates, and we used them to fit an ellipse curve. In the control case the 
isotropic distribution of chromosome at the maximal expansion tends to 
a 2D circle (i.e., major and minor axes of the elliptic curve are compa-
rable and their ratio tends toward 1). In case of a preferential direction 
expansion, the final spindle shape appears more elliptical, and therefore 
the ratio between major versus minor axis deviates from 1. Using the 
MAT LAB-implemented function fit ellipse, the major and minor axes 
of the elliptic cloud of chromosomes were estimated given the x and 
y coordinates of the chromosomes at the maximal spindle expansion. 
The ratio between the major and the minor axes was then computed for 
each experiment, and then experiments of each condition were pooled 
to build a distribution. We could then assess differences in expansion 
pattern by comparing distributions relative to different conditions. To 
statistically assess differences between distributions, we used a MAT 
LAB implementation of the Wilcoxon rank-sum test.
cDNA constructs
We used the previously described constructs for EGFP-mPlk4-pRN3P; 
hPlk4-mcherry-pRN3P, EGFP-ΔKinasePlk4-pRN3P, EGFP-Plk-
4T170A-pRN3P, EGFP-EB3pRN3P, H2B-mRFP-pRN3P (Coelho et 
al., 2013), and Aurora B-pRN3P (Sharif et al., 2010). Mouse Aurora 
A (clone IOM16362) was subcloned in frame with EGFP at the 3′ end 
into RN3P vector for in vitro transcription of mRNA. The plasmid for 
p150CC1 was a gift from X.  Zhu (Shanghai Institute for Biological 
Sciences, Chinese Academy of Sciences, Shanghai, China). p150CC1 
was subcloned into pRN3P for in vitro transcription.
Site-directed mutagenesis
For mutagenesis, the QuikChange II XL Site-Directed Mutagenesis 
kit (Stratagene) was used according to the manufacturer’s instructions. 
Oligonucleotides used are described in Table S5.
In vitro kinase assays
1.5 µg purified “kinase-dead” N-terminally 6His-tagged D274N Au-
rora A was incubated with 3 µg of N-terminally 6His-tagged WT Plk4 
(1–285) lacking the polo box domains or a catalytically inactive D154A 
Plk4 (1–264) mutant (±10 µM centrinone) at 37°C in 50 mM Tris, pH 
7.4, 10  mM MgCl2, 1  mM DTT, and 1  mM ATP. Aliquots were re-
moved at 0, 10, 30, 60, 120, and 240 min after reaction initiation and 
stopped by boiling in SDS sample buffer. To evaluate site-specific Au-
rora A phosphorylation, trypsin proteolysis and liquid chromatogra-
phy–tandem mass spectrometry (LC-MS/MS) analysis was performed 
at the 120-min time point.
Western blotting
In vitro kinase assays were analyzed by SDS-PAGE, after transfer onto 
a nitrocellulose membrane and probing with anti–Aurora A pThr288 
antibody (1:5,000) overnight at 4°C.  After washing with TBST and 
incubation with goat anti–rabbit IgG (1:5,000) for 1  h, pT288 Au-
rora A was visualized using ECL reagent. Equal loading of Aurora A 
D274N, WT and D154A Plk4 (1–285) was confirmed by Ponceau S 
staining of the membrane.
EZ Reader kinetic kinase assays for Aurora A
The Caliper LabChip EZ Reader platform measures enzyme activity 
by assessing the mobility shift of a fluorescently labeled peptide sub-
strate, which changes upon phosphorylation and can be quantified by 
comparative integration of phosphorylated and dephosphorylated pep-
tide peaks. To assess the effects of GST, GST-TPX2, WT PLK4, or 
kinase-dead (D154A) PLK4 on inactive Aurora A, a 10-fold molar ex-
cess of each protein was incubated with 100 ng lambda-phosphatase–
treated Aurora A with 1 mM ATP (to mimic the cellular concentration) 
and 10  mM MgCl2 for 30 min at 30°C.  Aurora A activity was then 
assessed in kinetic mode by the addition of a fluorescent kemptide-de-
rived peptide substrate (5FAM-Leu-Arg-Arg-Ser-Leu-Gly, with calcu-
lation of peptide phosphorylation every minute for 30 cycles at 20°C 
(1 min, approximately one cycle). To measure enhanced effects of WT 
PLK4 (1–285) on the activity of catalytically active (non–phosphatase 
treated) Aurora A, 2 µM of the Aurora A fluorescent kemptide-derived 
peptide substrate was incubated with 30 ng PLK4 and 10 ng Aurora A 
in 25 mM Hepes, 10 mM MgCl2, and 0.001% (vol/vol) Brij 35 buffer, 
with 1 mM ATP. Reactions were preincubated for 15 min at 37°C to 
permit activation of Aurora A, and measurements were taken over 60 
EZ Reader cycles at room temperature in kinetic mode.
Sample preparation for LC-MS/MS analysis
Disulfide bonds were reduced by addition of 3 mM DTT in 50 mM 
ammonium bicarbonate and heated at 60°C for 10 min. The resulting 
free cysteine residues were alkylated with 14 mM iodoacetamide (in 
the dark, at room temperature, for 30 min) and excess iodoacetamide 
quenched by addition of DTT to a final concentration of 7 mM. Pro-
teins were digested overnight with trypsin (2% wt/wt) at 37°C.
Mass spectrometry analysis
Nano-liquid chromatography electrospray ionization tandem mass 
spectrometry analysis was performed using a Thermo Fusion mass 
spectrometer attached to a Waters nanoAcquity ultra-high performance 
liquid chromatography system. Peptides were loaded onto the trapping 
column (PepMap100, C18, 300 µm × 5 mm; Thermo Scientific), using 
partial loop injection, for 7 min at a flow rate of 9  µl/min with 2% 
MeCN and 0.1% (vol/vol) trifluoroacetate and then resolved on an ana-
lytical column (Easy-Spray C18 75 µm × 500 mm 2-µm-bead-diameter 
column) using a gradient of 96.2% A (0.1% formic acid) and 3.8% B 
(80% MeCN, 19.9% H2O, and 0.1% formic acid) to 50% B over 30 min 
at a flow rate of 300 nl/min−1. A full-scan mass spectrum was acquired 
over m/z 400–1500 in the Orbitrap (60 K resolution at m/z 200) and 
data-dependent MS/MS analysis performed using a top-speed approach 
(cycle time of 3 s), using either higher-energy collisional dissociation 
(HCD) and/or electron-transfer and higher-energy collision dissocia-
tion (EThcD) for fragmentation, with product ions being detected in 
the ion trap (rapid mode). .raw files were converted to .mgf files in 
Proteome Discoverer. HCD and EThcD spectra were separated ac-
cording to electron-transfer dissociation reaction time (<39 ms selects 
HCD spectra) generating two separate .mgf files. Using an in-house 
built Perl script, the two .mgf files were merged and searched using 
MAS COT against the Escherichia coli IPI database, with the sequences 
of the human Aurora A and Plk4 constructs as targets. Parameters 
were set as follows: MS1 tolerance of 10 ppm, MS/MS mass toler-
ance of 0.6 D, carbamidomethylation of Cys as a fixed modification, 
and phosphorylation of Ser and Thr, and oxidation of Met as variable 
modifications. The tandem MS data for the identified phosphopeptides 
was interrogated manually.
Immunofluorescence and antibodies
Oocytes were fixed in ice-cold methanol/DMSO (9:1) for 30 min, fol-
lowed by permeabilization in 1× PBS 0.1% BSA, 10% FBS, and 0.5% 
Triton X-100 for 1 h and blocking in 1× PBS, 0.1% BSA, 0.1% Tween, 
and 10% FBS for another 1 h.  Incubation in primary and secondary 
antibodies was performed in 1× PBS, 0.1% BSA, 0.1% Tween, and 
10% FBS. Washes were performed using 1× PBS, 0.1% BSA, and 
0.1% Tween. Oocytes were mounted in Vectashield Mounting Medium 
with DAPI (Vector Laboratories). Images were collected on an SP5 
or SP8 (Leica) with 63×/1.4 oil objectives using the Application Suite 
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X software (LAS-X; Leica). Images were deconvolved using Huygens 
Professional software; processing and analysis was performed with Im-
ageJ Version 1.45 s and Photoshop CS5 (Adobe). All images shown are 
the projections of optical sections.
We used the following antibodies: rat anti–mouse PLK4 (de-
scribed in Coelho et al., 2013; 1:1,000); rat anti–α-tubulin-YL1/2 (1:50; 
Oxford Bioscences); mouse anti–α-tubulin-DM1A (1:10,000; Sigma); 
mouse anti–γ-tubulin-GTU88 (1:50; Sigma); rabbit anti–mouse Nedd1 
(gift from J.A. Manning, Centre for Cancer Biology, Adelaide, Aus-
tralia; described in Manning et al., 2008; 1:500); rabbit anti–human 
Cep192 (gift from L. Pelletier, Mt. Sinai Hospital, Toronto, ON, Can-
ada; described in Zhu et al., 2008; 1:500); rabbit anti-phospho-Ser626 
xTACC3 (gift from A.A. Hyman, Max Planck Institute of Molecular 
Cell Biology and Genetics, Dresden, Germany; described in Kinoshita 
et al., 2005; 1:750), and rabbit anti–human pAurAT288 (described in 
Tyler et al., 2007; 1:1,000).
The secondary antibodies used (1:1,000) were conjugated with 
Alexa Fluor 488, 568, or 647 (Invitrogen) and had minimal cross- 
reactivity to other species.
FRAP conditions and analysis
FRAP was performed with a spectral confocal (SP8; Leica) with a 
63×/1.4 NA objective lens and an additional zoom of 4.5×. Images 
were acquired every 10 ms or 1  s.  Bleaching was conducted for 10 
frames after five frames of prebleach imaging. 200 postbleach-
ing images were collected for 20.698  s.  Bleaching was performed 
with laser lines 476, 488, and 496 nm at 100% intensity and FRAP 
booster to expand the beam.
Pre- and postbleaching images were acquired with laser 488 
nm at 4.9% and laser 561 nm at 8.6%, under bidirectional XYZT 
scanning mode at 1,400 Hz.
Two types of ROIs were obtained for normalization: the refer-
ence ROI to measure a decay in fluorescence caused by the acquisi-
tion bleaching and the base ROI to establish the background of the 
oocyte. ROIs were always of the same area and shape as the ROIs used 
for photobleaching (9.1 µm2). Normalization for bleaching was per-
formed for each individual experiment. All FRAP experiments were 
performed at least three times. Replicates were biological replicates 
from different oocytes.
The values for fluorescence recovery at each time point were fit-
ted to this nonlinear curve: y = Ymax[1 − e^(−x * tau)], where t1/2 rep-
resents the time when the fluorescence recovery reaches the 50% of its 
maximal expansion, and tau represents the velocity of such a process:
  t 1/2 =  
− ln ​( 0.5 )  _______tau . 
The parameter vectors used to initialize the fitting procedure were 
[Ymax,Tau] = [1,10], where x corresponds to time and Y each individ-
ual normalized value of fluorescence.
Sample size for each experiment is given in Table S4. Data are 
shown as mean and 95% confidence intervals. Statistical significance 
was evaluated using Prism 7 (GraphPad software).
Online supplemental material
Fig. S1 shows that Plk4 inhibition by centrinone in the two-cell embryo 
prevents bipolar spindle formation. Figs. S2 and S3 show that Plk4 and 
Aurora A facilitate microtubule nucleation upon meiotic resumption. 
Fig. S4 shows that VX-680–mediated inhibition of Plk4 and Aurora A 
diminishes microtubule nucleation. Fig. S5 shows that Plk4 phosphor-
ylates Aurora A on five phosphosites in vitro. Table S1 lists p-values 
for the size of the projected spindle area. Table S2 shows values of t50 
and of the slope together with their relative confidence intervals. Table 
S3 shows inhibitor concentrations. Table S4 indicates FRAP values for 
t1/2, mobile fraction, and their relative confidence intervals. Video  1 
shows that Plk4 is required for acentriolar spindle assembly and re-
lates to Fig.  1. Video 2 shows that Aurora A plays a role in spindle 
assembly and relates to Figs. 2 and S2. Video 3 shows that Aurora A 
predominates over Plk4 to initiate microtubule nucleation and relates 
to Fig. 5. Video 4 shows that Ran has distinct functions from Aurora A 
and Plk4 during spindle assembly of meiosis.
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